nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts of the IV biennial winter workshop on schizophrenia in Badgastein, Austria
|
DeLisi, Lynn E. |
|
1988 |
1 |
2-3 |
p. 95- 1 p. |
artikel |
2 |
A CT scan follow-up study of cerebral ventricular size in schizophrenia and major affective disorder
|
|
|
1988 |
1 |
2-3 |
p. 165-166 2 p. |
artikel |
3 |
Acute amphetamine effect on neuropsychological testing in chronic schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 249-250 2 p. |
artikel |
4 |
Acute and chronic schizophrenia. A comparison of some psychopathological and biological variables — preliminary results
|
|
|
1988 |
1 |
2-3 |
p. 161-162 2 p. |
artikel |
5 |
Acute and subchronic effects of low-dose bromocriptine in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 204- 1 p. |
artikel |
6 |
A family study of chronic schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 126-127 2 p. |
artikel |
7 |
Affective disturbance in epilepsy
|
|
|
1988 |
1 |
2-3 |
p. 245-246 2 p. |
artikel |
8 |
A metaneurobiological synthesis of the schizophrenic syndromes
|
Cadet, Jean Lud |
|
1988 |
1 |
2-3 |
p. 254-255 2 p. |
artikel |
9 |
An ecological study of schizophrenia in Mannheim
|
|
|
1988 |
1 |
2-3 |
p. 117-118 2 p. |
artikel |
10 |
Animal studies of dopamine and decision making
|
|
|
1988 |
1 |
2-3 |
p. 242-243 2 p. |
artikel |
11 |
Antipsychotic effects of a presynaptic dopamine receptor agonist
|
|
|
1988 |
1 |
2-3 |
p. 204- 1 p. |
artikel |
12 |
Antipsychotics of the future
|
|
|
1988 |
1 |
2-3 |
p. 210-211 2 p. |
artikel |
13 |
Apomorphine-induced behavioral deficits: an animal model of negative symptomatology of schizophrenia?
|
|
|
1988 |
1 |
2-3 |
p. 241-242 2 p. |
artikel |
14 |
Are language changes in schizophrenia due to an executive dysfunction of prefrontal cortex?
|
|
|
1988 |
1 |
2-3 |
p. 194- 1 p. |
artikel |
15 |
Are sex differences in age of onset of schizophrenia related to phenomenological sub-types?
|
|
|
1988 |
1 |
2-3 |
p. 111-112 2 p. |
artikel |
16 |
A scale for rating drug-induced akathisia
|
|
|
1988 |
1 |
2-3 |
p. 249- 1 p. |
artikel |
17 |
Attentional deficits in schizophrenics as assessed by latent inhibition magnitude
|
|
|
1988 |
1 |
2-3 |
p. 193- 1 p. |
artikel |
18 |
Auditory P300 and smooth pursuit eye tracking abnormalities in schizophrenic subjects and their relatives
|
|
|
1988 |
1 |
2-3 |
p. 177-178 2 p. |
artikel |
19 |
Author index
|
|
|
1988 |
1 |
2-3 |
p. 257-260 4 p. |
artikel |
20 |
Beclamide as adjuvant of antipsychotic treatment
|
|
|
1988 |
1 |
2-3 |
p. 208- 1 p. |
artikel |
21 |
Before the beginning of schizophrenia: A clinical review
|
|
|
1988 |
1 |
2-3 |
p. 123-125 3 p. |
artikel |
22 |
Birthweight and psychosis in identical twins
|
|
|
1988 |
1 |
2-3 |
p. 122-123 2 p. |
artikel |
23 |
Blood-cerebrospinal fluid barrier in schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 149- 1 p. |
artikel |
24 |
Brain CT density in schizophrenic disorder
|
|
|
1988 |
1 |
2-3 |
p. 167-168 2 p. |
artikel |
25 |
Can psychiatry nurses ‘catch’ schizophrenia?
|
|
|
1988 |
1 |
2-3 |
p. 135-136 2 p. |
artikel |
26 |
Carbamazepine as an adjunct to antipsychotic treatment
|
|
|
1988 |
1 |
2-3 |
p. 207-208 2 p. |
artikel |
27 |
Clinical correlates of obstetric complications in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 125- 1 p. |
artikel |
28 |
Clonidine treatment of schizophrenia and treatment response prediction
|
|
|
1988 |
1 |
2-3 |
p. 205- 1 p. |
artikel |
29 |
Clozapine: Plasma levels, plasma HVA and prolactin, and clinical correlates
|
|
|
1988 |
1 |
2-3 |
p. 206-207 2 p. |
artikel |
30 |
Cognitive and emotional aspects of compliance during low-dose antipsychotic treatment: A pilot study
|
|
|
1988 |
1 |
2-3 |
p. 209- 1 p. |
artikel |
31 |
Comparison of ICD-10 research criteria for schizophrenic disorders with other diagnostic systems
|
|
|
1988 |
1 |
2-3 |
p. 102-103 2 p. |
artikel |
32 |
Computer-assisted pupillometry in schizophrenics with positive and negative symptoms
|
|
|
1988 |
1 |
2-3 |
p. 191- 1 p. |
artikel |
33 |
Continuous targeted medication in schizophrenic outpatients: Outcome results
|
|
|
1988 |
1 |
2-3 |
p. 223-224 2 p. |
artikel |
34 |
Cryptomyxoedema: An unrecognized syndrome in the elderly?
|
|
|
1988 |
1 |
2-3 |
p. 252-253 2 p. |
artikel |
35 |
CT correlates of obstetric complications in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 160-161 2 p. |
artikel |
36 |
Dexamethazone suppression test in positive and negative schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 148-149 2 p. |
artikel |
37 |
2-Dimensional electrophoresis of human lymphocyte proteins: Variations in schizophrenia and healthy controls
|
|
|
1988 |
1 |
2-3 |
p. 134- 1 p. |
artikel |
38 |
Diminished slow wave sleep and ventricular enlargement in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 164-165 2 p. |
artikel |
39 |
Distinction between positive and negative schizophrenia in the light of psychophysiological measurements
|
|
|
1988 |
1 |
2-3 |
p. 179-180 2 p. |
artikel |
40 |
DNA repair synthesis and lipid peroxidation in schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 152- 1 p. |
artikel |
41 |
Do antipsychotic drugs have specific effects on protein metabolism?
|
|
|
1988 |
1 |
2-3 |
p. 218-219 2 p. |
artikel |
42 |
Domains of psychopathology relevant to the study of etiology and treatment in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 111- 1 p. |
artikel |
43 |
Dopamine D2-receptors in postmortem putamen from schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 140-141 2 p. |
artikel |
44 |
Dopamine infusion and intracerebral injection models: value for the detection of potential antipsychotic activity
|
|
|
1988 |
1 |
2-3 |
p. 217-218 2 p. |
artikel |
45 |
Dopamine receptor changes with limbic kindling
|
|
|
1988 |
1 |
2-3 |
p. 238-239 2 p. |
artikel |
46 |
Dopamine receptor subtypes and the arousal-sedation continuum
|
|
|
1988 |
1 |
2-3 |
p. 239-240 2 p. |
artikel |
47 |
Drug therapy in schizophrenia — prediction of outcome
|
|
|
1988 |
1 |
2-3 |
p. 222- 1 p. |
artikel |
48 |
Effects of schizophrenic CSF on human neuroblastoma cells
|
|
|
1988 |
1 |
2-3 |
p. 151- 1 p. |
artikel |
49 |
Electromechanical characteristics of tardive dyskinesia
|
|
|
1988 |
1 |
2-3 |
p. 234- 1 p. |
artikel |
50 |
Evidence of glutamatergic dysfunction in orbital frontal cortex and left temporal lobe in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 142-143 2 p. |
artikel |
51 |
Excitatory amino acid receptor subtypes in postmortem schizophrenic hippocampi
|
|
|
1988 |
1 |
2-3 |
p. 143-144 2 p. |
artikel |
52 |
Expressed emotion and the course of disease in schizophrenic outpatients — results of an 18-month follow-up
|
|
|
1988 |
1 |
2-3 |
p. 226- 1 p. |
artikel |
53 |
Expressive dysprosody in schizophrenia — a right frontal deficit?
|
|
|
1988 |
1 |
2-3 |
p. 189-190 2 p. |
artikel |
54 |
Eye movements as a marker of schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 178-179 2 p. |
artikel |
55 |
Failure to replicate abnormalities of the P50 component of the AEP in schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 183- 1 p. |
artikel |
56 |
Family history and cerebral ventricular enlargement in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 162- 1 p. |
artikel |
57 |
Functional changes of neuronal networks in schizophrenics — a pet study of brain regional glucose metabolism
|
|
|
1988 |
1 |
2-3 |
p. 175-176 2 p. |
artikel |
58 |
Genetic linkage studies of schizophrenia using minisattelite and chromosome 5 DNA polymorphisms
|
|
|
1988 |
1 |
2-3 |
p. 130-131 2 p. |
artikel |
59 |
Genetic marker studies in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 128-129 2 p. |
artikel |
60 |
Gestalt Perception in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 196- 1 p. |
artikel |
61 |
Glutamatergic abnormality in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 144-146 3 p. |
artikel |
62 |
Handedness and schizophrenia in twins
|
|
|
1988 |
1 |
2-3 |
p. 252- 1 p. |
artikel |
63 |
Harvey-RAS-1 and insulin gene in schizophrenia. Initial findings in five Scottish pedigrees
|
|
|
1988 |
1 |
2-3 |
p. 131-132 2 p. |
artikel |
64 |
Highlights on treatment refractory schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 211-212 2 p. |
artikel |
65 |
High reduced haloperidol/haloperidol ratio and poor clinical outcome in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 221- 1 p. |
artikel |
66 |
How to identify residual syndromes
|
|
|
1988 |
1 |
2-3 |
p. 109-111 3 p. |
artikel |
67 |
3H-spiperone binding to lymphocytes of schizophrenics: Family investigations
|
|
|
1988 |
1 |
2-3 |
p. 127-128 2 p. |
artikel |
68 |
Immunological aspects of schizophrenia: Neopterin as an in vivo marker of cellular immunity
|
|
|
1988 |
1 |
2-3 |
p. 137-138 2 p. |
artikel |
69 |
Impact of a training program on cognitive deficits in schizophrenics
|
|
|
1988 |
1 |
2-3 |
p. 214- 1 p. |
artikel |
70 |
Impairments on neuropsychological tests of temporo-hippocampal and fronto-hippocampal functions and word fluency in remitting schizophrenia and affective disorders
|
|
|
1988 |
1 |
2-3 |
p. 191-192 2 p. |
artikel |
71 |
Incentive learning, dopamine and schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 236- 1 p. |
artikel |
72 |
Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 174- 1 p. |
artikel |
73 |
Initial treatment of schizoaffective psychoses
|
|
|
1988 |
1 |
2-3 |
p. 199- 1 p. |
artikel |
74 |
Intermittent medication in schizophrenia — preliminary results
|
|
|
1988 |
1 |
2-3 |
p. 224-225 2 p. |
artikel |
75 |
Inter-rater reliability of positive and negative symptoms between Italian and Spanish interviewers
|
|
|
1988 |
1 |
2-3 |
p. 114-115 2 p. |
artikel |
76 |
Is it possible to have an animal model of schizophrenic symptoms?
|
|
|
1988 |
1 |
2-3 |
p. 235- 1 p. |
artikel |
77 |
Is there gliosis in schizophrenia? Comparison of techniques
|
|
|
1988 |
1 |
2-3 |
p. 153-154 2 p. |
artikel |
78 |
IV biennial winter workshop on schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 97-100 4 p. |
artikel |
79 |
IV biennial winter workshop on schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 93- 1 p. |
artikel |
80 |
Late event related potentials in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 182-183 2 p. |
artikel |
81 |
Laterality in schizophrenia: A study using syllable recognition and dot location tasks
|
|
|
1988 |
1 |
2-3 |
p. 190- 1 p. |
artikel |
82 |
Lateralized asymmetry of temporal horn enlargement in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 155-156 2 p. |
artikel |
83 |
Left globus pallidus hyperactivity and right-sided hemineglect in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 174-175 2 p. |
artikel |
84 |
Left hemisphere dysfunction and negative symptoms in schizophrenia: Some EEG evidence
|
|
|
1988 |
1 |
2-3 |
p. 184-185 2 p. |
artikel |
85 |
Limbic and paralimbic pathology in schizophrenia: The role of age and stress
|
|
|
1988 |
1 |
2-3 |
p. 154-155 2 p. |
artikel |
86 |
Low dose fluphenazine decanoate and skills training in schizophrenic outpatients
|
|
|
1988 |
1 |
2-3 |
p. 213- 1 p. |
artikel |
87 |
Magnetic resonance brain imaging, perinatal injury and negative symptoms in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 171-172 2 p. |
artikel |
88 |
Magnetic resonance in schizophrenia: A multiplanar approach to brain morphology
|
|
|
1988 |
1 |
2-3 |
p. 172-173 2 p. |
artikel |
89 |
Magnetic resonance in schizophrenia: An update and overview
|
|
|
1988 |
1 |
2-3 |
p. 168-169 2 p. |
artikel |
90 |
Measurement of the alpha-cell-migration in the entorhinal region: A marker for the developmental disturbances in schizophrenia?
|
|
|
1988 |
1 |
2-3 |
p. 157-158 2 p. |
artikel |
91 |
Mechanisms of action of novel antipsychotic agents
|
|
|
1988 |
1 |
2-3 |
p. 216-217 2 p. |
artikel |
92 |
Models for dopamine autoreceptors, behavior and microdialysis
|
|
|
1988 |
1 |
2-3 |
p. 240-241 2 p. |
artikel |
93 |
Multidimensional analysis of CT parameters in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 158-159 2 p. |
artikel |
94 |
Multivariate analysis of CSF monoamines, their metabolites, serum prolactin and dopamine-beta-hydroxylase in schizophrenics
|
|
|
1988 |
1 |
2-3 |
p. 140- 1 p. |
artikel |
95 |
Neurobiological correlates of stress in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 250-251 2 p. |
artikel |
96 |
Neurophysiological evaluation of different forms of distraction and thought disorder in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 192-193 2 p. |
artikel |
97 |
NMR changes following ECT in major mental disorders
|
|
|
1988 |
1 |
2-3 |
p. 171- 1 p. |
artikel |
98 |
Norepinephrine and relapse prediction
|
|
|
1988 |
1 |
2-3 |
p. 228- 1 p. |
artikel |
99 |
On the prediction of outcome from psycho-physiological, psychobiological and psychological variables
|
|
|
1988 |
1 |
2-3 |
p. 227- 1 p. |
artikel |
100 |
On the way to expert systems: Computerized DSM-III and ICD diagnoses in cross-sectional and longitudinal perspective
|
|
|
1988 |
1 |
2-3 |
p. 104-105 2 p. |
artikel |
101 |
Organic risk factors and antecedents of functional psychosis
|
|
|
1988 |
1 |
2-3 |
p. 121-122 2 p. |
artikel |
102 |
Partial da-agonists as potential anti-schizophrenic agents
|
|
|
1988 |
1 |
2-3 |
p. 202-203 2 p. |
artikel |
103 |
Patients' attitudes to depot neuroleptics
|
|
|
1988 |
1 |
2-3 |
p. 209-210 2 p. |
artikel |
104 |
Polydiagnostic assessment of schizophrenic disorders by a structured interview (PODI)
|
|
|
1988 |
1 |
2-3 |
p. 106-107 2 p. |
artikel |
105 |
Post-ictal psychoses of epilepsy
|
|
|
1988 |
1 |
2-3 |
p. 247-248 2 p. |
artikel |
106 |
Postmortem messenger RNA analysis in control and psychiatric subjects
|
|
|
1988 |
1 |
2-3 |
p. 131- 1 p. |
artikel |
107 |
Prediction of response to low dose fluphenazine
|
|
|
1988 |
1 |
2-3 |
p. 225-226 2 p. |
artikel |
108 |
Prolonged reaction times (RT) after stimulus alternation in schizophrenics: further explorations
|
|
|
1988 |
1 |
2-3 |
p. 196-197 2 p. |
artikel |
109 |
Psychiatric consequences of temporal lobectomy
|
|
|
1988 |
1 |
2-3 |
p. 246- 1 p. |
artikel |
110 |
Reduced temporal lobe area: An MRI study of siblings with schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 169-170 2 p. |
artikel |
111 |
Relapse after lithium withdrawal in schizoaffective psychoses
|
|
|
1988 |
1 |
2-3 |
p. 212-213 2 p. |
artikel |
112 |
Relationship between CT findings, pregnancy and birth complications and premorbid adjustment in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 159-160 2 p. |
artikel |
113 |
Saccadic eye movements in acute schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 181- 1 p. |
artikel |
114 |
Schizophrenia and HIV
|
|
|
1988 |
1 |
2-3 |
p. 136- 1 p. |
artikel |
115 |
Schizophrenia in the UK Afro-Caribbean population
|
|
|
1988 |
1 |
2-3 |
p. 119- 1 p. |
artikel |
116 |
Schizophrenic symptom patterns and abnormal somatosensory evoked potentials
|
|
|
1988 |
1 |
2-3 |
p. 181-182 2 p. |
artikel |
117 |
Schizophreniform diagnosis: Long-term clinical profile
|
|
|
1988 |
1 |
2-3 |
p. 105-106 2 p. |
artikel |
118 |
Serotonergic mechanisms in chronic schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 146-147 2 p. |
artikel |
119 |
Sex differences in age at first onset of schizophrenic disorders
|
|
|
1988 |
1 |
2-3 |
p. 120- 1 p. |
artikel |
120 |
Stability of psychiatric diagnosis: Follow-up investigation of patients with delusional psychoses
|
|
|
1988 |
1 |
2-3 |
p. 107-108 2 p. |
artikel |
121 |
Studies of dopamine systems in schizophrenia using post mortem brain tissue
|
|
|
1988 |
1 |
2-3 |
p. 141-142 2 p. |
artikel |
122 |
Tactile memory test in schizophrenics and their first-degree relatives
|
|
|
1988 |
1 |
2-3 |
p. 187-188 2 p. |
artikel |
123 |
Tardive dyskinesia and cognitive dysfunction
|
|
|
1988 |
1 |
2-3 |
p. 232-233 2 p. |
artikel |
124 |
Tardive dyskinesia may be due to an increase d1/d2 receptor ratio in the brain
|
|
|
1988 |
1 |
2-3 |
p. 230- 1 p. |
artikel |
125 |
Tardive dystonia — a case report
|
|
|
1988 |
1 |
2-3 |
p. 229-230 2 p. |
artikel |
126 |
The activity of 5-HT3 receptor antagonists in animal models of schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 237-238 2 p. |
artikel |
127 |
The dopamine hypothesis of schizophrenia: Pros and cons
|
|
|
1988 |
1 |
2-3 |
p. 139- 1 p. |
artikel |
128 |
The dopaminergic system and the behavioral control of non-reinforcement
|
|
|
1988 |
1 |
2-3 |
p. 243-244 2 p. |
artikel |
129 |
The effect of the partial dopamine agonist transdihydrolisuride on negative symptoms in schizophrenics
|
|
|
1988 |
1 |
2-3 |
p. 203- 1 p. |
artikel |
130 |
The effects of CIS- and trans-flupenthixol upon gene expression in the rat brain: A study of the mechanism of action of antipsychotic drugs
|
|
|
1988 |
1 |
2-3 |
p. 219-220 2 p. |
artikel |
131 |
The effects of relative groups on the psychosocial functioning of schizophrenic patients
|
|
|
1988 |
1 |
2-3 |
p. 226- 1 p. |
artikel |
132 |
The finnish adoptive family study of schizophrenia: Possible joint effects of genetic vulnerability and family environment
|
|
|
1988 |
1 |
2-3 |
p. 133- 1 p. |
artikel |
133 |
The genetics of schizophrenia in relation to affective disorders
|
|
|
1988 |
1 |
2-3 |
p. 129-130 2 p. |
artikel |
134 |
The Lewisham schizophrenia survey
|
|
|
1988 |
1 |
2-3 |
p. 117- 1 p. |
artikel |
135 |
The method of nasopharyngeal EEG recordings from structures near the Hippocampus in schizophrenic patients and normals
|
|
|
1988 |
1 |
2-3 |
p. 185-186 2 p. |
artikel |
136 |
The narrow therapeutic index of HPL: A dose comparison study
|
|
|
1988 |
1 |
2-3 |
p. 201-202 2 p. |
artikel |
137 |
The nature and prevalence of depression in chronic schizophrenic inpatients
|
|
|
1988 |
1 |
2-3 |
p. 109- 1 p. |
artikel |
138 |
The negative/positive dimension of schizophrenia in Europe: The neojacksonism of Henry Ey
|
|
|
1988 |
1 |
2-3 |
p. 101-102 2 p. |
artikel |
139 |
The signs of brain vulnerability in tardive dyskinesia
|
|
|
1988 |
1 |
2-3 |
p. 231- 1 p. |
artikel |
140 |
The stability of electrodermal behavior in schizophrenics during acute psychosis
|
|
|
1988 |
1 |
2-3 |
p. 195- 1 p. |
artikel |
141 |
The use of intracerebral dopamine infusion models to detect potential antipsychotic agents
|
|
|
1988 |
1 |
2-3 |
p. 214-215 2 p. |
artikel |
142 |
The VBR in schizophrenia research: A methodological problem
|
|
|
1988 |
1 |
2-3 |
p. 163-164 2 p. |
artikel |
143 |
Thought and language disorder
|
|
|
1988 |
1 |
2-3 |
p. 116- 1 p. |
artikel |
144 |
Three-component-system-hypothesis of psychosis: a psychopharmacological-neuropsychological approach
|
|
|
1988 |
1 |
2-3 |
p. 190-191 2 p. |
artikel |
145 |
Three syndromes in chronic schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 112-113 2 p. |
artikel |
146 |
Towards a unified disease theory of neuroleptic-responsive and neuroleptic-resistant psychoses
|
|
|
1988 |
1 |
2-3 |
p. 113-114 2 p. |
artikel |
147 |
Transmembranal signaling in schizophrenic and affective disorders: Studies on arachidonic acid and phospholipids
|
|
|
1988 |
1 |
2-3 |
p. 150- 1 p. |
artikel |
148 |
Unimanual and bimanual tapping speed in schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 197-198 2 p. |
artikel |
149 |
Ventricular and cranial size in schizophrenia: A 4 to 7 year follow-up
|
|
|
1988 |
1 |
2-3 |
p. 163- 1 p. |
artikel |
150 |
Visual evoked potentials and schizophrenia
|
|
|
1988 |
1 |
2-3 |
p. 187- 1 p. |
artikel |
151 |
Vulnerability to involuntary movements in relation to family history of schizophrenia and obstetric complications
|
|
|
1988 |
1 |
2-3 |
p. 233-234 2 p. |
artikel |
152 |
Zotepine vs. haloperidol in acute schizophrenia: A double blind trial
|
|
|
1988 |
1 |
2-3 |
p. 200-201 2 p. |
artikel |